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Juvenile neuronal ceroid lipofuscinosis (JNCL) is a fatal childhood-onset neurodegenerative disorder caused by mutations in ceroid
lipofuscinosis neuronal-3 (CLN3), a hydrophobic transmembrane protein of unresolved function. Previous studies indicate blood– brain
barrier (BBB) defects in JNCL, and our earlier report showed prominent Cln3 expression in mouse brain endothelium. Here we find that
CLN3 is necessary for normal trafficking of the microdomain-associated proteins caveolin-1, syntaxin-6, and multidrug resistance
protein 1 (MDR1) in brain endothelial cells. Correspondingly, CLN3-null cells have reduced caveolae, and impaired caveolae- and
MDR1-related functions including endocytosis, drug efflux, and cell volume regulation. We also detected an abnormal blood– brain
barrier response to osmotic stress in vivo. Evaluation of the plasma membrane with fluorescent sphingolipid probes suggests microdo-
main destabilization and enhanced fluidity in CLN3-null cells. In further work we found that application of the glycosphingolipid
lactosylceramide to CLN3-deficient cells rescues protein transport and caveolar endocytosis. Last, we show that CLN3 localizes to the
trans-Golgi network (TGN) and partitions with buoyant microdomain fractions. We propose that CLN3 facilitates TGN-to-plasma mem-
brane transport of microdomain-associated proteins. Insult to this pathway may underlie BBB dysfunction and contribute to JNCL
pathogenesis.
Introduction
The neuronal ceroid lipofuscinoses (NCLs; Batten disease) are a
family of neurodegenerative diseases with shared features, caused
by mutations in distinct genes. The juvenile form (JNCL) is
caused by recessive inheritance of mutations in CLN3, encoding
the CLN3 protein. JNCL typically presents at approximately age 7
with visual impairment that rapidly progresses to blindness, fol-
lowed by seizures, motor and mental decline, and death within
the second decade (Jalanko and Braulke, 2009). CLN3 is a 438 aa
protein with six predicted membrane-spanning regions, and has
been variously reported to localize to the Golgi, trans-Golgi net-
work (TGN), lysosomes, or autophagic vesicles. The molecular
function of CLN3 is unresolved and the literature indicates im-
pact on diverse cell processes including vesicular trafficking, pH
regulation, arginine transport, autophagy, and lipid transport or
metabolism (Phillips et al., 2005; Cotman and Staropoli, 2012).
Despite broad CLN3 expression, JNCL symptoms are largely
restricted to the CNS. Our knock-in reporter mouse, with
nuclear-targeted bacterial -galactosidase (-gal) driven by the
endogenous Cln3 promoter, indicates Cln3 expression in neuro-
nal subsets and in endothelial cells throughout the vasculature
(Eliason et al., 2007). Consistent with this, CLN3 was previously
detected in endothelial cells in human brain tissue sections (Mar-
graf et al., 1999). Prior reports of circulating autoantibodies to
brain antigens, brain IgG deposition, and focal leakage of tracers
in a different CLN3-deficient mouse model (Lim et al., 2006,
2007) suggest blood– brain barrier (BBB) damage with JNCL
progression. We thus hypothesized that CLN3 was critical to nor-
mal functioning and health of BBB endothelial cells.
Endothelial cells lining the CNS vasculature are a major compo-
nent of the BBB. Their tight junctions, drug efflux, and transcytosis
properties govern selective molecular trafficking between the blood
and the brain parenchyma (Löscher and Potschka, 2005; Predescu et
al., 2007). Endothelial cells have abundant caveolae: flask-shaped
invaginations in the plasma membrane (PM) that serve as critical
foci for signaling cascades and endocytic entry (Parton and Simons,
2007; Lajoie and Nabi, 2010). Caveolae are considered specialized
cholesterol/sphingolipid-rich membrane microdomains, in which
caveolin-1 is an essential scaffolding protein. Caveolin-1 assembles
into higher-order multimers within microdomains upon transit
from the TGN to the PM. Recent lipidomic studies in yeast show that
microdomain lipids (sterol and sphingolipids) segregate into TGN-
derived carriers that deliver lipids and protein cargo to the PM
(Klemm et al., 2009; Surma et al., 2011). Little information exists
concerning microdomain-facilitated transport from mammalian
TGN, or the regulatory or stabilizing contribution of proteins to this
transport pathway.
Herein we examined CLN3 in relation to endothelial cell func-
tion and membrane microdomain-related proteins. We provide
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intriguing new data showing that CLN3 is necessary for normal
caveolin-1 transport and caveolae formation, as well as for traf-
ficking of other microdomain-related proteins syntaxin-6 and
multidrug resistance protein 1 (MDR1) in brain vascular endo-
thelial cells. In correlation, CLN3-null cells display impaired
caveolae- and MDR1-dependent functions, and abnormal PM
sphingolipid dynamics. Furthermore, we find that CLN3 local-
izes to intracellular compartments bearing TGN and lipid mi-
crodomain markers, implicating a direct role for CLN3 in
microdomain-facilitated transport from the TGN to the PM.
Materials and Methods
Animals. All animal experiments were approved by the University of
Iowa Animal Care and Use Committee and were conducted in accor-
dance with institutional and federal guidelines. The CLN3-null mice
used in this study (Cln3 lacZ/lacZ) have a nuclear-localized E. coli
-galactosidase gene (lacZ) recombined in the Cln3 locus and have been
backcrossed to C57BL/6 mice for 10 generations. A mix of male and
female mice were used for these studies.
Cell culture. Primary mouse brain endothelial cells cultures were pro-
duced as previously described (Song and Pachter, 2003). The low yield of
purified brain endothelial cells from mouse brains precludes the use of
primary cultures for experiments requiring large cell numbers, and in-
curs substantial time and animal costs for multiple experiments. To over-
come this, we generated immortalized mouse brain endothelial cell lines
(MBECs) from primary cultures of Cln3 lacZ/lacZ and Cln3 / mice, us-
ing a previously described method (Klingelhutz et al., 1994). Briefly,
replication-defective recombinant murine leukemia virus carrying hu-
man papilloma virus E6 and E7 oncogenes and pseudotyped with the
VSV-G envelope glycoprotein (B-MLV-LXSH-E6/E7) was added to day
4 primary cultures at 16  10 5 transducing U/well, with 1% polybrene in
a 24-well plate for 24 h. Hygromycin (25 g/ml; Invitrogen, Carlsbad)
was started 1 week later and continued until noninfected control cultures
died off. MBECs are maintained in DMEM:F12 (Invitrogen) with 10%
FBS, and 1% penicillin/streptomycin. Endothelial cultures expressed the
endothelial cell marker Von Willebrand factor, formed ZO-1-positive
tight junctions, and were devoid of astrocytes, neurons, and smooth
muscle cells as assessed by immunohistochemistry. To generate
MBEC Cln3-R, CLN3 was stably reintroduced into MBEC lacZ/lacZ by trans-
duction with a replication deficient feline immunodeficiency virus
(FIV)-based lentiviral vector (FIVRSVCln3CMVmCherry) at 1  10 6
transducing U/well and 1% polybrene in a 24-well plate. This vector was
constructed by the University of Iowa Gene Transfer Vector Core
(http://www.uiowa.edu/gene/) with murine Cln3 cloned 3 to the Rous
sarcoma virus (RSV) promoter and mCherry cloned 3 to the CMV
promoter, and pseudotyped with the VSV-G envelope glycoprotein. In-
fection with the lentiviral vector was highly efficient (80% mCherry-
positive cells), and CLN3-restored cells (red fluorescent cells) were
selected by sorting on a Becton-Dickinson FACS DiVa. MBEC lacZ/lacZ
and MBEC Cln3-R thus represent CLN3-negative and -positive versions of
the same cell line.
The Cln3 sequences cloned into all constructs used in this study refer
to the 438 aa coding region of murine transcript NM_009907.3. In some
experiments CLN3 was transiently reintroduced into immortalized
MBECs by transfection with a Cln3 expression plasmid (pBUDRSVCln3)
using Lipofectamine LTX (Invitrogen). This plasmid was constructed by
cloning the murine Cln3 into pBUDRSV, 3 of the RSV promoter, and 5
of the BGHpA. pBUDRSV was constructed by cloning the RSV promoter
into the multiple cloning site of pBUDmcs. pBUDmcs was derived from
pBUDCE4 (Invitrogen) by removing the CMV promoter and replacing
the EF1 promoter with a multiple cloning site.
Transmission electron microscopy and caveolae quantification. Endothe-
lial cell cultures were fixed with 2.5% glutaraldehyde in 0.1 M sodium
cacodylate buffer for 1 h. For in vivo analysis, mice were perfused with
2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer and 50 m vi-
brotome sections were cut. Samples (cultures or brain sections) were
then postfixed in 1% osmium tetroxide for 1 h, stained with uranyl
acetate, dehydrated in a graded ethanol series, and embedded in Epon
resin. Ultrathin 70 nm sections were cut on a Leica UC6 ultramicrotome
(Leica Microsystems) and analyzed with a 1230 JEOL-JEM transmission
EM (Jeol USA) at 6000. For caveolae quantification, the total number
of endothelial cell caveolae (flask-shaped invaginations connecting with
apical or basolateral PM) in EM images were counted, and endothelial
cell PM length was determined using ImageJ software (NIH). Results are
expressed as caveolae per m membrane. For cell cultures, EM images
were collected from three independent cultures per genotype, for a total
of 100 EM images per genotype. For in vivo endothelium, horizontal
sections of the primary motor and somatosensory cortices between layers
IV and VI of the parietal cortex from three mice per genotype were
analyzed. For this, EM images were captured to reconstruct complete
cross-sectional views of 15 vessels per group, and total endothelial cell
caveolae counted.
Endocytosis experiments. MBECs were incubated with Alexa488-
transferrin (A488-Tfn) or A488-BSA for 30 min at 37°C, 5% O2, as pre-
viously described (Marks et al., 2005). Cells were then rinsed three times
with ice-cold PBS, and fresh media with 100 mM red-40 dye added to
quench extracellular fluorescence. Cells were kept on ice until image
capture with an inverted fluorescence microscope (Olympus IX70 with
DP70 camera). Quantifications were performed by analysis of captured
images using ImageJ software. For inhibition of dynamin-dependent
endocytosis, cells were incubated in cell media containing 80 M dyna-
sore (Abcam) for 30 min. Media was replaced with cell culture media
containing 50 g/ml A488-BSA, 80 M dynasore, and Hoeschst 33342 for
30 min. This solution was removed and extracellular fluorescence was
quenched with 100 mM red-40 before image capture as described above.
High performance thin-layer chromatograpy. Lipids were extracted
from MBEC lacZ/lacZ and MBEC Cln3-R cell pellets and cholesterol and
neutral sphingolipids (ceramide, hexosylceramides, and sphingomy-
elin,) were separated by high performance thin-layer chromotography
and quantified by densitometry as previously described (Farwanah et al.,
2009). Quantities were determined from calibration curves of corre-
sponding lipid standards, and normalized to protein level in initial
lysates.
BODIPY-LacCer staining and LacCer treatment. Plasma membrane
(PM) microdomains were labeled using LacCer (Avanti Polar Lipids)
and BODIPY-LacCer (Invitrogen) according to Marks et al. (2005). Cells
were loaded at 4°C by incubating with 20 M unlabeled LacCer, followed
by 2.5 M BODIPY-LacCer. Cells were placed on ice until image capture.
In some experiments, media with 50 mM red-40 dye was added after
staining to quench extracellular (PM-localized) BODIPY-LacCer fluo-
rescence. Cells were analyzed with an Olympus IX70 inverted fluores-
cence microscope equipped with LCPlan FL 60 (NA 0.7), and HMC
LWD PL FL 40 (NA 0.6) lenses and 480  20/535  25 nm and 480 
30/630  30 nm filters (Chroma Technology) for monomer and excimer
signals, respectively. Images were captured with an Olympus DP70 cam-
era and DP Controller 2.1 software. Image levels were adjusted equally,
with Adobe Photoshop CS3.
For LacCer treatment, cells were loaded by incubating with 20 M
unlabeled LacCer for 30 min at 4°C, then incubated a further 30 min at
37°C before analyzing phenotypes.
FRAP analysis. Fluorescence recovery after photobleaching (FRAP)
analysis was performed on a Zeiss LSM510 microscope (Carl Zeiss)
equipped with an Ar 488 nm laser. Cells were incubated with A488-
CTB (Invitrogen) for 30 min and maintained at 10°C throughout the
experiment to avoid internalization. After rinses with ice-cold media,
photobleaching was performed with 60 iterations at 100% of 488 nm
excitation and 31 pixel diameter areas were bleached. Postbleach im-
ages were captured every 5 s. FRAP was quantified as described by
Kenworthy (2007).
Immunofluorescent staining. Cells were fixed with 4% paraformalde-
hyde in PBS for 10 min at room temperature and blocked and perme-
abilized (10% goat or donkey serum and 0.1% Triton X-100 in PBS) for
1 h at room temperature. Cells were incubated with primary antibody in
PBS containing 2% goat or donkey serum overnight at 4°C, Alexa-
conjugated cholera toxin subunit B (CTB) or wheat germ agglutinin
(WGA; Invitrogen) at 5 g/ml for 20 min at room temperature, then
Alexa-conjugated secondary antibody (Invitrogen) at 1:2000 for 1 h at
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room temperature. For some experiments cell nuclei were stained by 2
min incubation with Hoechst 33342 dye. Cells were coverslipped with
Fluoro-Gel mounting media (Electron Microscopy Sciences) and ana-
lyzed by confocal microscopy using a Zeiss LSM710 microscope with a
Plan-Apochromat 63 objective (NA 1.4) and ZEN software. For all
immunofluorescent staining, secondary alone controls were included
and found to give no or negligible signal. Primary antibodies used were
rabbit anti-Von Willebrand factor (Dako), anti zonula occludin-1
(ZO-1, Zymed), goat anti-MDR1 (Santa Cruz Biotechnology), mouse
anti-syntaxin-6, anti-phosphorylated caveolin-1 (Y14), rabbit anti-
caveolin-1 (BD Transduction Laboratories), anti-TGN46 (Sigma-
Aldrich), and anti-GM130 (BD Transduction Laboratories). CLN3
specific mouse polyclonal antisera was generated in our lab by tail vein
injection of Cln3 lacZ/lacZ mice with 5  10 8 plaque-forming units of
replication-deficient recombinant adenovirus vector encoding murine
CLN3, driven by the CMV promoter (University of Iowa Gene Transfer
Vector Core; http://www.uiowa.edu/gene/). Affinity purified rabbit
polyclonal antibody to murine CLN3 peptide (aa 244 –257) was gener-
ated by NeoBioscience.
TIRF. Total internal reflection fluorescence (TIRF) microcopy was
performed using a Leica AM TIRF Imaging System (Leica Microsystems)
with a HCX PL APO 63 NA 1.47 lens. MBECs were transfected with a
plasmid expressing GFP-tagged caveolin-1 (kindly provided by Amit
Choudhury, University of Iowa), using Lipofectamine LTX, and 18 –24 h
later images were captured. For TIR illumination, GFP was excited at 488
nm using an argon laser, with a stimulated penetration depth of 90 nm.
TIR images were captured for cells demonstrating similar transfection
levels, based on epi-illumination. TIR and epi-illumination setting were
identical for all cells within an experiment. Images were analyzed using






Fractionation on sucrose gradients and Western blots. For fractionation
of PM microdomains, MBECs from three confluent 160-mm-diameter
dishes were harvested and PM isolated and subjected to detergent-free
sodium carbonate extraction and centrifugation over a discontinuous
sucrose density gradient as previously described (Yao et al., 2009). For
fractionation of TGN microdomains, TGN-enriched fractions were iso-
lated and subjected to carbonate extraction and discontinuous sucrose
density centrifugation as previously described (Waugh et al., 2011). Then
120 l fractions were carefully collected from top to bottom, mixed with
Laemmli sample buffer, and 50 l of each loaded onto 12% SDS/PAGE
gels. Proteins were transferred onto PVDF membranes and incubated
with anti-syntaxin-6, rabbit anti-caveolin-1 (BD Transduction Labora-
tories), or mouse anti-human transferrin receptor (Zymed) followed by
HRP-coupled secondary antibodies (Jackson ImmunoResearch). For
dot blot, 2 l of each fraction were applied to nitrocellulose membranes
(Immobilon-NC, Millipore) using a Minifold-1 dot-blot acrylic system
(Schleicher and Schuell BioScience). Dot blots were air-dried, blocked
and incubated with peroxidase-conjugated CTB (Invitrogen), which
binds to GM1 lipid, for detection of raft lipid-positive fractions. Western
and dot blots were developed with ECL-Plus (GE Healthcare). Results
were analyzed with a VersaDoc Imaging System (Bio-Rad) and Quantity
One 4.6 software, and bands/dots were quantified by densitometry using
Quantity One 4.6 software.
For analysis of CLN3 partitioning to lipid microdomains, MBEClacZ/lacZ
were transfected with either pBUDRSVCln3, encoding Cln3, or with
pBUDmcs-negative control plasmid. Transfections were performed us-
ing Lipofectamine LTX (Invitrogen). At 24 h post-transfection mem-
brane microdomains were isolated from transfected MBECs using
detergent-free, carbonate extraction and centrifugation over a discontin-
uous sucrose gradient as previously described (Song et al., 1996). Frac-
tions were collected and samples analyzed by SDS-PAGE and Western
blot, or by dot blot, with blocking and washing steps as described above.
For Western blot, CLN3 was detected using murine polyclonal antisera at
1/500, followed by HRP-coupled secondary.
For Western blot analyses of syntaxin-6, and total and phosphorylated
caveolin-1 protein levels, confluent MBECs in 60 mm dishes were rinsed
twice with ice-cold PBS and lysed with RIPA lysis buffer (150 mM NaCl,
10 mM Tris pH 7.4. 0.1% SDS, 1% Triton X-100, 1% deoxycholate, 5 mM
EDTA) supplemented with mini Complete Protease Inhibitors (Roche)
or HALT (ThermoScientific). Protein concentrations in lysates were de-
termined Bio-Rad Dc-Protein assay (Bio-Rad) and equilibrated. Samples
were mixed with NuPAGE sample buffer and reducing agent and run on
NuPAGE 10% Bis-Tris Gels (Invitrogen), and transferred onto PVDF
membranes. Immunodetection was performed with syntaxin-6, caveolin-1,
and P(Tyr14)-caveolin-1 antibodies described above, and with rabbit
anti--catenin (Abcam). Blots were immune-stained and developed as
described above. Protein bands were quantified by densitometry using
Quantity One 4.6 software, with each band normalized to -catenin in
the same lane.
Drug efflux assay. MBECs were seeded at 5000 cells per well in human
placenta collagen IV precoated 96-well black plates (Costar). The next
day, cells were incubated with 0.5 M calcein-AM (Invitrogen) for 1 h at
37°C. After two rinses with ice-cold calcein-AM-free media, baseline
intracellular fluorescence was determined by reading the plate on a
FLUOstar plate reader (BMG Lab Technologies) using 485 nm/538 nm
(ex/em) filters. The cells were returned to the incubator at 37°C, 5% CO2
for 1 h, washed as before, and a second fluorescent measurement ob-
tained. Efflux was determined as the difference between the first and
second measurements.
Volume regulation analysis. Cell volume changes were determined us-
ing a method similar to that previously described (Srinivas et al., 2003).
Primary brain endothelial cell cultures from Cln3 / and Cln3 lacZ/lacZ
mice were grown as monolayers in transwells (6.5 mm diameter, 0.4 m
pore size, polyester membrane; Costar, Corning) precoated with human
placenta collagen IV (Sigma-Aldrich). Just before analysis, cell surfaces
were biotinylated by incubation with 1.5 mg/ml sulfo-NHS-SS-biotin
(Thermo Scientific) for 1 h at 37°C, 5% CO2. After two rinses with
ice-cold PBS, cells were incubated with 4 l/ml FluoSpheres NeutrAvidin
microspheres (1.0 m diameter; Invitrogen) for 1 h at 37°C, 5% CO2.
After washing monolayers with media, transwells were placed on a glass
bottom culture dish (MatTek). Iso-osmoalar media was placed below (5
l) and in (40 l) the transwell. Timed confocal z-series images were
collected through the depth of the monolayer using a Zeiss LSM 510
microscope with LSM software. After the first series, the transwell me-
dium was made hypo-osmotic by addition of 20 l of water to the trans-
well (final 30% water). Cell volume changes were determined by
measuring the change in fluorescence intensity at the top confocal plane
and at the bottom confocal plane. Using ImageJ, fluorescence intensities
of four separate fields of view for upper and lower confocal planes were
determined, with background fluorescence subtracted and intensities
normalized to area. The average fluorescence intensity between at 0 and
14 min was determined for upper and lower confocal planes.
Blood– brain barrier permeability assay. Seven 5-month-old mice per
group were anesthetized and given intracarotid injection of 100 l of
Hoechst 33258 (100 g/ml, Invitrogen) dissolved in 1 mM CaCl2 hypo-
tonic solution, injected over 30 s. For positive controls of BBB disruption,
Cln3 / mice were given intraperitoneal injection of 3 ml/100 g body
weight 20% D-mannitol (Sigma-Aldrich) 10 min before intracarotid in-
jection of isotonic Hoechst solution. Thirty minutes after tracer injec-
tion, mice were perfused with 15 ml of 4% PFA intraventricularly, before
brain harvest. Brains were cryoprotected with 30% sucrose, embedded in
OCT (Tissue-Tek, Sakura Finetek), and 40 m cryosections were
mounted on glass plus slides and analyzed by microscopy (Olympus
BX60 and camera Olympus DP70).
Statistics. Data with normal distributions (D’Agostino normality test)
were analyzed by Student’s t test (calcein-AM efflux, A488-BSA uptake)
and data without normal distributions were analyzed by Wilcoxon rank
sum test (A488-Tfn uptake, immunoblot densitometry, FRAP, TIRF,
caveolae number), using GraphPad Prism5. Shifts in the distribution
across sucrose density gradients were analyzed by two-way ANOVA.
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Results
Reduced caveolae and caveolae-dependent endocytosis in
CLN3-deficient brain endothelial cells
To study CLN3 function in brain endothelial cells, we prepared
cultures of murine brain microvascular endothelial cells from
Cln3 lacZ/lacZ and wild-type counterparts (Cln3/). Cln3 lacZ/lacZ
mice carry the -gal reporter gene in place of Cln3 exons 1– 8, and
are CLN3-null (Eliason et al., 2007). We examined primary cul-
tures by EM and were struck by the paucity of caveolae in the
CLN3-deficient cells relative to Cln3/ cells (Fig. 1A). We
Figure 1. Reduced caveolae and caveolae-dependent endocytosis in CLN3-null endothelial cells. A, Primary brain endothelial cell cultures and brain sections from the motor/somatosensory
cortex of Cln3 / and CLN3-null (Cln3 lacZ/lacZ) mice were processed and examined by transmission EM. Representative EM images are shown for endothelial cells in primary culture and in vivo.
Arrows indicate caveolae. Scale bars, 500 nm. For quantification, caveolae were counted in multiple EM images collected from three independent cultures per group or from brains of three mice per
group, and data are expressed as the number of caveolae per m of PM. Data points for cultured cells (top graph) represent individual EM images, while data points for in vivo analysis (bottom graph)
represent individual vessels in cross-section; mean  SEM are indicated by long/short horizontal bars, respectively; ***p  0.001. B, Immortalized (MBECs) or primary brain endothelial cells were
immunostained for Von Willebrand factor (VW; endothelial marker, red fluorescence) and for zonula occludens-1 (ZO-1, tight junction marker, green fluorescence). MBEC images are lacZ/lacZ and
are representative of all genotypes. C, Immortalized (MBECs) or primary brain endothelial cells were incubated with A488-Tfn or A488-BSA and endocytosis analyzed by fluorescence microscopy.
Images are representative of 3–5 experiments. Scale bars, 20 m. D, The quantity of internalized A488-Tfn or A488-BSA was determined using ImageJ software analysis and is expressed as the
mean  SEM (***p  0.001, 20 –50 cells analyzed per group).
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counted caveolae in 100 EM images each for control and
CLN3-null primary cultures, and verified a significant decrease
(0.08  0.02 mean caveolae per m membrane compared with
0.35  0.03 for control; Fig. 1A). To confirm this phenotype in
vivo, EM images were overlaid to recreate cross-sectional views of
15 distinct vessels per genotype, and endothelia examined for
caveolae. Representative EM images taken from brain sections
are shown in Figure 1A. Similar to cultured cells, a significant
reduction in caveolae was observed in brain endothelia from
CLN3-null mice (Fig. 1A; 0.10  0.02 mean caveolae per micro-
meter membrane compared with 0.40  0.10 for control).
To investigate the functional impact of reduced caveolae,
we generated immortalized mouse brain endothelial cells
(MBECs) from Cln3 lacZ/lacZ and Cln3/ mice. In addition, we
used a lentiviral vector to stably reintroduce CLN3 to the MBE-
C lacZ/lacZ, creating a CLN3-restored sister cell line (MBEC Cln3-R).
The MBECs exhibit brain endothelial markers and features (Fig.
1B) and serve as valuable tools for this study (see Materials and
Methods for details). Herein we compared CLN3-null versus
CLN3-expressing MBECs, often with confirmation in primary
brain endothelial cell cultures.
The specific influence of CLN3 on caveolae-dependent endo-
cytosis has not previously been delineated. Therefore, we fol-
lowed uptake of fluorescently conjugated BSA and transferrin
(Tfn) as indicators of caveolae- and clathrin-based endocytosis,
respectively (Cheng et al., 2006). Binding of Tfn (iron-loaded) to
the Tfn receptor triggers internalization into clathrin-coated
vesicles. In contrast, BSA is internalized primarily via caveolae-
dependent endocytosis. Caveolae-based endocytosis is clathrin-
independent, and in endothelial cells is initiated by BSA binding
to gp60 at the cell surface (Tiruppathi et al., 1997). To assess
internalization, MBECs were incubated with either Alexa-488-
Tfn (A488-Tfn) or Alexa-488-BSA (A488-BSA). Fluorescent im-
ages were captured after 30 min (Fig. 1C), and relative levels of
internalization were quantified with Im-
ageJ software (Fig. 1D). A488-Tfn uptake
was not significantly different between
MBEC lacZ/lacZ and MBEC Cln3-R cells. In
contrast, endocytosis of A488-BSA was
markedly and significantly diminished
in MBEC lacZ/lacZ relative to MBEC Cln3-R.
Primary endothelial cell cultures behaved
in identical fashion to the immortalized
MBECs; clear defects in BSA uptake were
observed in the CLN3-null cells (Fig.
1C,D). Caveolar but not fluid-phase en-
docytosis relies on dynamin. Thus as an
assurance that A488-BSA uptake into
MBECs was occurring via caveolae-based
and not via fluid-phase endocytosis, we
pretreated the cultures for 30 min with
80 M of the dynamin-inhibitory drug
dynasore before addition of A488-BSA
and assessment of endocytosis. Dynasore
completely blocked A488-BSA uptake
into MBECs (data not shown), confirm-
ing the dynamin dependence of A488-
BSA uptake in these cells. Together our
data suggest that CLN3 is dispensable for
clathrin-dependent endocytosis, but is re-
quired for normal caveolae-dependent
endocytosis.
MBECs require CLN3 for normal caveolin-1 transport
and phosphorylation
We next used immunofluorescent microscopy and Western blot
to determine whether changes in the subcellular distribution or
abundance of caveolin-1 might account for the scarcity of cave-
olae in CLN3-null MBECs, and resultant endocytic defect. The
fluorescent staining intensity for caveolin-1 was dramatically
reduced in the MBEC lacZ/lacZ line compared with MBEC Cln3-R,
particularly at cell– cell junctional regions at the PM (Fig. 2A).
Immunoblot however revealed no difference in the total amount
of caveolin-1 (Fig. 2B), indicating that reduced detection by im-
munofluorescence was a consequence of altered intracellular dis-
tribution rather than a drop in protein level. We next transfected
MBECs with GFP-caveolin-1 and used TIRF microscopy to di-
rectly observe GFP-caveolin-1 on the basal PM. GFP-caveolin-1
was more prominent at the PM of MBEC Cln3-R compared with
MBEC lacZ/lacZ (Fig. 2C). Quantification of TIRF images revealed
a striking 50% drop in PM caveolin-1 in the absence of CLN3
(Fig. 2C), suggesting that CLN3 is required for normal antero-
grade trafficking of caveolin-1.
As phosphorylation of caveolin-1 at tyrosine-14 is a critical
step in caveolae-based endocytosis in endothelial cells (Sverdlov
et al., 2007), we examined the phosphorylation status of
caveolin-1 in relation to CLN3. By both immunofluorescent
staining and immunoblot approaches, we found that pTyr14-
Cav1 was significantly reduced in MBEC lacZ/lacZ relative to
MBEC Cln3-R (Fig. 2A,B). Reduced immunofluroescent detection
of pTyr14-Cav1 in the absence of CLN3 was similarly demon-
strated in primary endothelial cell cultures (Fig. 2A). Collectively
these findings indicate that CLN3 promotes caveolin-1 delivery
to the PM for the formation of caveolae and endocytic signaling
platforms.
Delivery of caveolin-1 and other microdomain-associated
proteins from the TGN to the PM is regulated by the t-SNARE
Figure 2. CLN3 promotes normal trafficking of caveolin-1. A, CLN3-expressing and nonexpressing endothelial cells were
stained for caveolin-1 and P(Tyr14)-Caveolin-1 and analyzed by confocal microscopy. Cell nuclei were stained with Hoechst dye
(blue). Representative images are shown. Scale bars, 20 m. B, Lysates from CLN3-deficient (lacZ/lacZ) or restored (Cln3-R) MBECs
were assayed by SDS-PAGE and immunoblot for caveolin-1 (cav-1) and P(Tyr14)-Caveolin-1 (P-cav-1). Bands were quantified and
normalized to -catenin by densitometric analysis. Bars show mean  SEM (n  6 experiments); **p  0.01. C, Twenty-four
hours after transfection with GFP-caveolin-1 plasmid, live TIRF images of MBEC lacZ/lacZ and MBEC Cln3-R were captured. Represen-
tative images are shown. Scale bars, 20 m. PM levels of GFP-caveolin-1 were determined by analyzing captured TIRF images with
LAS AF software, and the bar graph shows the mean  SEM intensity for each group (***p  0.001, 50 cells analyzed per group).
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protein, syntaxin-6 (Choudhury et al.,
2006), which localizes primarily at the
TGN (Jung et al., 2012). Immunofluores-
cent staining showed syntaxin-6-positive
vesicles concentrated near the nucleus in
both CLN3-expressing and null cells, but
with reduced intensity in CLN3-null cells,
and Image J analysis verified this differ-
ence (Fig. 3A). However, similar to
caveolin-1, immunoblot quantification
revealed similar total levels of syntaxin-6
(Fig. 3B), suggesting that the diminished
immunofluorescent signal results from a
more diffuse molecular distribution of
syntaxin-6. We used wheat germ aggluti-
nin (WGA) as a TGN marker to deter-
mine whether syntaxin-6 localization to
the TGN was perturbed. While a proportion
of syntaxin-6 clearly colocalized to WGA-
positive perinuclear compartments in both
MBEClacZ/lacZ and MBECCln3-R (Fig. 3C),
Pearson’s analysis revealed a statistically sig-
nificant drop in the correlation coefficient in
the absence of CLN3, indicating altered dis-
tribution of syntaxin-6 relative to WGA. In
addition, WGA staining revealed a fractured
and less-polarized TGN in MBEClacZ/lacZ,
compared with a more compact, polarized
appearance in CLN3-expressing MBECs.
Staining patterns for the cis-Golgi markers
GM130 and giantin were not different be-
tween MBEClacZ/lacZ and MBEC Cln3-R
(Fig. 3D). The coordinate mislocaliza-
tion of both caveolin-1 and syntaxin-6
in the absence of CLN3, and abnormal
morphology of the TGN implicates a novel
role for CLN3 in the TGN-to-PM transport
of microdomain-associated proteins.
Impaired MDR1 distribution, drug
efflux and volume regulation in CLN3-
null MBECs
Our findings that CLN3 is important for
caveolin-1 transport and BSA endocytosis
prompted investigation of additional
caveolae-dependent endothelial cell pro-
cesses. Multidrug resistance protein 1
(MDR1, P-glycoprotein, ABCB1) is highly
expressed on the luminal surface of brain
vascular endothelial cells, where it mediates apical efflux of numer-
ous small molecules (Schinkel et al., 1994). In BBB endothelial cells,
MDR1 localizes to caveolae and demonstrates functionally relevant
binding to caveolin-1 (Jodoin et al., 2003). To assess drug efflux
function in the MBECs, we used calcein-AM, a cell permeable dye
which is hydrolyzed to a nonpermeable product in the cytoplasm
and requires MDR1 (or MRP1, ABCC1) for subsequent efflux. After
loading with calcein-AM, intracellular fluorescence was measured at
time 0, and again at 60 min to determine efflux. We observed a 40%
reduction in efflux from MBEClacZ/lacZ relative to MBEC/ (Fig.
4A). Correspondingly, MDR1 staining intensity was reduced in
MBEClacZ/lacZ compared with MBEC/ (Fig. 4B). Thus, CLN3-
deficient cells are impaired in drug efflux, likely as a consequence
of reduced MDR1 incorporation into caveolar microdomains at
the PM.
In addition to its drug transport activity, MDR1 is also known
to participate in regulatory volume decrease (RVD). RVD occurs
in reaction to hypotonic exposure: cell swelling immediately trig-
gers K or Cl	 efflux, which is followed by osmotically obliged
efflux of water, resulting in cell volume decrease and restoration
of original (or slightly below original) cell volume. MDR1 fulfills
a proximal role in RVD by enhancing the activation of swelling-
activated Cl	 channels (Valverde et al., 1996; Wang et al., 1998).
To determine whether CLN3 affects RVD, we coated apical cell
surfaces of primary endothelial cell cultures with fluorescent mi-
crobeads, and followed bead displacement after hypotonic shock
(30% H2O addition) by confocal z-series image capture. Data
Figure 3. CLN3 promotes normal trafficking of syntaxin 6. A, CLN3-expressing and nonexpressing endothelial cells were stained
for syntaxin-6 (syn6) and analyzed by confocal microscopy. Cell nuclei (blue dye) are shown. Scale bars, 20 m. Fluorescence
intensity was quantified in MBECs. Bars show the mean  SEM for each group (*p  0.05, 32 cells analyzed per group). B,
SDS-PAGE and immunoblot analyses for syntaxin-6 was performed as in Figure 2. Bars show mean  SEM of four experiments. C,
Colocalization analyses for syntaxin-6 (green) and WGA (red) in CLN3-deficient (lacZ/lacZ) or restored (Cln3-R) MBECs. Cell nuclei
were stained with Hoechst dye (blue). Pearson’s correlation coefficients were calculated for red/green channels for lacZ/lacZ and
Cln3-R MBECs and bars show mean  SEM (***p  0.001, 32 cells per group). All fluorescence quantifications were performed
using ImageJ software. D, MBEC lacZ/lacZ and MBEC Cln3-R cells were immunofluorescently stained for cis-Golgi markers GM-130 or
giantin. Representative confocal images are shown. Scale bar, 10 m.
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were continuously collected from 12 horizontal planes spanning
12 micrometers, from the base of the cells to above the beads (Fig.
4C). For CLN3-null endothelial cell cultures, we found that from
time 0 to14 min posthypotonic shock the fluorescence became
significantly more intense in the upper plane, and less intense in
the lower plane, indicating upward bead movement, and swollen
cells. In contrast, normal RVD was triggered in wild-type cul-
tures, such that by 14 min the cell volume receded to slightly
below the starting value. These results implicate CLN3 as critical
for the RVD process in brain vascular endothelial cells. Collec-
tively our data support a role for CLN3 in normal MDR1 trans-
port and function at the PM.
We next assessed the in vivo response to hypotonic exposure at
the BBB. To accomplish this we infused hypotonic solutions of
Hoechst 33258 tracer into the carotid artery of CLN3-deficient
(Cln3 lacZ/lacZ) and wild-type (Cln3/) mice, and assessed pas-
Figure 4. CLN3 is necessary for normal drug efflux and cell volume regulation in brain endothelial cells. A, MBECs were loaded with calcein-AM and efflux was determined by measuring decrease
in intracellular fluorescence after 1 h. Bars shown mean  SEM drop in fluorescence (*p  0.05, n  3 independent experiments). B, MBECs were immunofluorescently stained for MDR1 and
analyzed by confocal microscopy. Settings for image capture were identical between compared cell types. Representative images are shown. Scale bar, 20 m. C, Apical membranes of primary brain
endothelial cultures were labeled with 1.0 m diameter FluoSpheres and confocal z-series images were collected through the depth of the monolayer, under isotonic starting conditions (time 0) and
after hypotonic challenge (30% water). Fluorescence intensity was quantified in focal planes 1 and 12 at time 0, and after 14 min using ImageJ software and bars show mean  SEM (***p  0.001).
D, Cln3 / and Cln3 lacZ/lacZ mice were given an intracarotid injection of hypotonic tracer (Hoechst 33258) and killed 30 min later. For positive controls for BBB disruption, Cln3 / mice were given
D-mannitol (i.p. 20% mannitol in isotonic saline) 10 min before an intracarotid injection of isotonic tracer (labeled as D-mannitol). Brains were analyzed by fluorescence microscopy (n  7 mice per
group). Settings for image capture and for image adjustment (MetaMorph software) were identical between groups. Representative images from cerebral cortex are shown.
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sage into the brain. Hoechst 33258 is a small (562D) aqueous
soluble dye, and is used as a sensitive indicator of BBB disruption
(Nitta et al., 2003; del Valle et al., 2008; Pfeiffer et al., 2011). At 30
min after injection, Hoechst-positive nuclei were abundant in the
brain parenchyma of Cln3/ brain tissue sections, whereas pos-
itive nuclei were restricted to the blood vessels in Cln3 lacZ/lacZ
sections (Fig. 4D). These results are consistent with our in vitro
data; in Cln3/ mice, the hypotonic injection triggers RVD with
overshoot, creating transient loss of tight junctions and paracel-
lular passage of tracer. In contrast, the brain endothelium in
CLN3-null mice is devoid of RVD and BBB integrity is main-
tained under these conditions. The in vivo response to hypotonic
challenge may additionally or alternatively involve transcytosis of
tracer. Support for hypo-osmotic influence on transcytosis
comes from studies in kidney epithelium, where introduction of
an osmotic gradient across the polarized barrier triggers transcy-
tosis (Lauer and Minuth, 1988; Reid and O’Neil, 2000). As cave-
olae act as portals for transcytosis in endothelial cells (Predescu et
al., 2007), impaired transcytosis may occur in the absence of
CLN3. Together our experiments highlight reduced endothelial
cell performance in caveolae- and MDR-1-dependent cellular
processes, with altered in vivo responses to an osmotic gradient.
Under unstressed conditions, BBB integrity was qualitatively
intact in JNCL and control mice (data not shown). This contrasts
a previous report in another JNCL mouse model, using differ-
ent experimental methods (Lim et al., 2007). Interestingly,
caveolin-1 has proposed roles in both the stabilization of tight
junctions (Song et al., 2007), and in chemokine-induced loss of
tight junctions (Stamatovic et al., 2009) in BBB models. Perhaps
tight junctions are maintained early on by low level PM
caveolin-1 or compensatory mechanisms, but deteriorate in vul-
nerable areas with disease progression and increased neuroin-
flammation (Pontikis et al., 2004, 2005).
CLN3 modulates membrane microdomain properties
Our findings of altered trafficking of microdomain-related pro-
teins and functions led us to investigate membrane properties.
We first took a biochemical approach to assess partitioning of
caveolin-1 and syntaxin-6 to membrane domains isolated from
cell lysates. To avoid artifacts related to lipid reassembly during
detergent extraction (Lichtenberg et al., 2005), we used a
detergent-free, carbonate-based extraction method for microdo-
main fractionation (Song et al., 1996; Yao et al., 2009). Golgi- or
PM-enriched membranes from cell lysates were sonicated, ex-
tracted with carbonate to remove loosely associated proteins, and
separated by centrifugation over a sucrose density gradient. With
this method, separation of membrane fragments is based on
buoyancy, which correlates with increased lipid–protein ratio
and enrichment for cholesterol and sphingolipids (Ortegren et
al., 2004; Yao et al., 2009). Fractions collected from top to bottom
of the gradients were analyzed by Western blot for caveolin-1 and
syntaxin-6, and by dot blot for the GM1, a microdomain-
enriched sphingolipid (Fig. 5A). Caveolin-1 and syntaxin-6 par-
titioned to buoyant fractions in both MBEC lacZ/lacZ and
MBEC Cln3-R. However, in the absence of CLN3, the fractions
containing the most abundant concentrations of caveolin-1 and
syntaxin-6 were shifted toward earlier, more buoyant ones for
both PM and TGN membranes. We measured this shift by den-
sitometric analysis of the bands across fractions for three
(caveolin-1) or two (syntaxin-6) separate experiments, as illus-
trated in the Figure 5A histograms. A similar shift toward to
lighter fractions was detected for GM1 in the PM (Fig. 5A). To-
gether with Figures 2 and 3 these results suggest that without
CLN3, altered composition of TGN and PM membrane domains
occurs and negatively influences TGN-to-PM transport of
caveolin-1 and syntaxin-6.
We addressed the possible impact of CLN3 on the biosynthe-
sis of microdomain-related lipids by extracting total lipids from
MBEC lacZ/lacZ and MBEC Cln3-R and quantifying by high perfor-
mance TLC. No significant differences were found for any of the
lipids analyzed (sphingomyelin, ceramide, hexosylceramides,
and cholesterol; Fig. 5B), suggesting that the defects in trafficking
of microdomain-related proteins in CLN3-deficient MBECs are
not a consequence of gross deficiency of these lipids. The possi-
bility of changes in subclasses of these lipids or other lipids, or
disturbance in subcellular compartmentalization of lipids re-
quires further exploration.
We next ascertained the influence of CLN3 on PM mi-
crodomain properties in live cells. Microdomains (or lipid
rafts) are conventionally thought of as relatively stable, mi-
croscale cholesterol/sphingolipid-enriched membrane regions
with more ordered lipid packing relative to a general disordered
lipid arrangement in the surrounding membrane (Simons and
Ikonen, 1997; Pike, 2004). This original concept has been chal-
lenged by the recent advancement of super-resolution optical
methods that indicate that sphingolipid/cholesterol-based do-
mains exist as transient nanoscale entities on the PM (Eggeling et
al., 2009; Simons and Gerl, 2010). However, perturbation in
protein-lipid and protein-protein interactions can modulate raft
composition, size and tendency to coalesce into more stable,
functionally relevant microdomains (Pike, 2006; Lingwood and
Simons, 2010). Micrometer-size regions of heterogeneity on the
PM of live cells are indeed detected by using BODIPY-labeled
sphingolipid probes (Marks et al., 2005; D’Auria et al., 2011). The
BODIPY fluorophore exhibits monomer/excimer emission, such
that intermolecular proximity induces a green-to-red spectral
shift, allowing distinction of membrane domains that tightly
pack the BODIPY-tagged lipid (Marks et al., 2005). We loaded
the PM of MBEC at 4°C with BODIPY-lactosylceramide
(BODIPY-LacCer) and assessed the cells by fluorescence micros-
copy. Green (515 nm) monomer signal was distributed across the
PM, and was similar in MBEC Cln3-R and MBEC lacZ/lacZ, indicat-
ing equal loading (Fig. 5C). In contrast, the red (620 nm) exci-
mer signal, designating microdomains, was substantially stronger
in the MBEC Cln3-R and highlighted many large PM patches, as
opposed to primarily small puncta in the MBEC lacZ/lacZ (Fig. 5C).
As an assurance that the BODIPY-LacCer remained at the
PM and was not internalized, we applied a cell-impermeant
fluorescence-quenching red dye to the media after staining.
This dye completely eliminated fluorescence (Fig. 5D), indi-
cating PM origin. Our results suggest that in CLN3-null cells,
PM microdomains as defined by BODIPY-LacCer accumula-
tion and excimer signal have reduced propensity to coalesce
and have decreased lipid-order.
Next we examined whether sphingolipid mobility within the
PM was affected by CLN3. To assess this we followed the move-
ment of Alexa-488-conjugated cholera toxin subunit B (A488-
CTB) using FRAP. CTB demonstrates high-affinity, multivalent
binding to GM1, a sphingolipid which localizes to the outer leaf-
let of the PM and is enriched in microdomains. A488-CTB was
applied to intact cells, and after focal photobleaching of a 2 m
diameter area within a GM1-rich region, the rate of A488-CTB
(green fluorescence) movement into the area was measured.
FRAP analysis revealed a faster recovery rate in MBEC lacZ/lacZ
compared with MBEC Cln3-R (Fig. 5E), indicating enhanced
movement of CTB-GM1 into the bleached region, suggestive of
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Figure 5. CLN3 affects microdomain properties. A, Golgi- and PM-enriched membranes were isolated from MBEC Cln3-R and MBEC lacZ/lacZ lysates, carbonate-extracted, sonicated and centrifuged
over a sucrose gradient. Fractions were analyzed for caveolin-1 (cav-1) and syntaxin-6 (syn6) by Western blot, and GM1-containing fractions were identified by dot-blot. Densitometry was
performed on the blots and histograms show the distribution of caveolin-1 (three experiments), syntaxin-6 (two experiments), and GM1 (three experiments; PM shown) across fractions, expressed
as the mean  SEM percentage of the total of all fractions ( p  0.001 for all comparisons of curve shifts of MBEC lacZ/lacZ to MBEC Cln3-R data). B, Total lipids were extracted from MBEC lacZ/lacZ and
MBEC Cln3-R and analyzed by quantitative high performance thin-layer chromatography. Results show mean relative abundanceSEM (n 3 separate cultures). C, Apical surfaces of live MBEC Cln3-R
and MBEC lacZ/lacZ were labeled with BODIPY-LacCer. Images were captured at 535  25 nm (green) and 630  30 nm (red). Green fluorescence indicates loading of BODIPY-LacCer into the PM. Red
fluorescence identifies liquid-ordered membrane domains, with close packing of BODIPY-LacCer molecules. Results are representative of three separate experiments. Scale bar, 10 m. D, Apical
surfaces of live MBEC Cln3-R were labeled with BODIPY-LacCer and images were captured before (left) and immediately after (right) addition of impermeable red-40 dye to the media to quench
extracellular (PM localized) BODIPY-LacCer fluorescence. Scale bar, 20 m. E, GM1 in the PM of live MBEC lacZ/lacZ and MBEC Cln3-R was labeled with A488-CTB, and cells maintained at 20°C for FRAP
analysis. Photobleaching was performed with 60 iterations at 100% of 488 nm excitation and 31-pixel diameter areas were bleached. Postbleach images were captured every 5 s. Representative
FRAP images are shown. Scale bar, 5 m. Data shown is mean  SEM fluorescence intensity (n  11 or 12 cells) and is representative of 3 experiments. p  0.0001, recovery of MBEC lacZ/lacZ
compared with MBEC Cln3-R.
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increased membrane fluidity within GM1-rich domains in
CLN3-deficient cells. This finding is consistent with reduced
BODIPY-LacCer excimer signal, and strengthens a scenario in
which CLN3 imparts order and stability to membrane domains.
It is possible that CLN3 localizes to microdomains to influ-
ence their properties. However, currently available antibodies do
not reliably detect endogenous levels of CLN3. Thus, we trans-
fected MBEC lacZ/lacZ with a CLN3 expression plasmid, and took
two approaches to assess CLN3 localization to membrane do-
mains. First, after fixing and permeabilizing, we dual stained
MBECs with A488-CTB (to label GM1) and antibodies to murine
CLN3, and assessed overlap by confocal microcopy. CLN3 was
not apparent on the PM of transfected cells, and as expected was
predominantly vesicular. By confocal analysis, substantial GM1
and CLN3 colocalization was observed within intracellular com-
partments, particularly in vesicles concentrated in the perinu-
clear region of cells (Fig. 6A). Dual staining for CLN3 and Golgi
markers indicated that CLN3 signal was distinct from, though
proximal to, the cis-Golgi marker GM130. CLN3 showed overlap
with the TGN marker TGN46, and prominent overlap with
WGA-labeled intracellular compartments (Fig. 6A). These re-
sults place CLN3 within the TGN/post-TGN compartment, pu-
tatively along a microdomain-dependent anterograde transport
pathway.
As a second approach to examining CLN3 presence in mem-
brane domains we determined whether CLN3 partitioned to
lipid-rich buoyant fractions, using the nondetergent, carbonate
extraction method. CLN3 clearly partitioned to buoyant frac-
tions (Fig. 6B). By dot blot, these fractions harbor GM1-enriched
membrane microdomains (Fig. 6B). Partitioning of CLN3 to
these buoyant fractions is consistent with localization in
cholesterol/sphingolipid-rich microdomains in TGN/post-TGN
compartments. Several other investigators have reported Golgi/
TGN residence for CLN3 at physiological, nonoverexpressed lev-
els (Kremmidiotis et al., 1999; Persaud-Sawin et al., 2004; Codlin
and Mole, 2009), or describe adverse Golgi/TGN phenotypes in
CLN3-deficient cells (Metcalf et al., 2008; Codlin and Mole,
2009). Localization of CLN3 to the TGN and to buoyant mem-
brane domains implicates CLN3 in microdomain-associated
transport in brain endothelial cells.
Lactosylceramide corrects phenotypes in CLN3-null MBECs
Because CLN3-deficient MBECs have altered sphingolipid mo-
bility and a reduced tendency of membrane domains to form
larger microdomains, as determined by the Bodipy-LacCer assay,
we next tested whether sphingolipid addition might reverse cel-
lular defects. LacCer has been previously shown to promote
microdomain formation and enhance caveolar endocytosis
(Sharma et al., 2005). We added LacCer to MBEC lacZ/lacZ and
MBEC Cln3-R and incubated for 30 min at 4°C followed by 30
min at 37°C to allow for LacCer integration into PM domains
and retrograde transport to Golgi (Marks et al., 2005; Cheng et
al., 2006). MBECs were then fixed and immunofluorescently
stained. Remarkably, LacCer treatment normalized caveolin-1,
syntaxin-6, and MDR1 localization in CLN3-deficient MBECs
(Fig. 7A).
Caveolae-dependent endocytosis was also assessed after Lac-
Cer treatment. For this, MBECs were pretreated with LacCer
before addition of A488-BSA, and A488-BSA internalization
analyzed 30 min later by fluorescence microscopy. LacCer treat-
ment normalized A488-BSA uptake in MBEC lacZ/lacZ to
MBEC Cln3-R levels (Fig. 7B). Therefore, addition of LacCer rees-
tablishes transport of caveolin-1 and MDR1, and importantly,
corrects caveolae-dependent endocytosis in CLN3-deficient
MBECs. These restorative effects are exciting and may present a
promising avenue for JNCL therapies.
Discussion
Our study is novel in demonstrating defects in the transport of
the microdomain-localized proteins caveolin-1, MDR1 and
syntaxin-6 in the absence of CLN3, and in linking these defects to
disturbances in physical properties of microdomains. Moreover
ours is the first description of CLN3 partitioning to buoyant mi-
crodomain fractions, isolated by a detergent-free method. Col-
lectively our findings implicate CLN3 as having a direct influence
on membrane domain-coupled transport pathways from the
TGN to the PM.
Reduced caveolin-1 transport to the PM and impaired
caveolae-dependent functions were prominent findings in this
study. Caveolae-based endocytosis was markedly diminished by
CLN3 loss. We also uncovered a strict dependence on CLN3 for
RVD in endothelial cells as well as a role for CLN3 in drug efflux,
likely reflecting a dependence on CLN3 for correct MDR1 traf-
ficking to PM caveolae in brain endothelial cells. RVD pathways
are not entirely understood, and may invoke distinct molecular
players in different cells types. Interestingly, both MDR1 and
caveolin-1 have described roles in RVD; MDR1 has an immediate
Figure 6. CLN3 localization to TGN and membrane microdomains. A, MBEC lacZ/lacZ were
transfected with empty control plasmid (pBUD-mcs) or a CLN3 expression plasmid (pBUD-
CLN3). Twenty-four hours post-transfection cells were fixed, permeabilized, and dual stained
for CLN3 and a marker for GM1 microdomains (A488-CTB), TGN (WGA or TGN46), or cis-Golgi
(GM130). Stained cells were analyzed by confocal microscopy. Representative images are
shown. Scale bars, 20 m. B, MBEC lacZ/lacZ transfected as in A were extracted with carbonate
and fractionated over a discontinuous sucrose gradient. Fractions from top to bottom were
analyzed by Western blot for CLN3 and by dot blot for GM1.
18074 • J. Neurosci., November 13, 2013 • 33(46):18065–18079 Tecedor et al. • CLN3 Loss Alters Endothelia Cell Function
role in triggering anion efflux (Valverde et al., 1996), whereas
caveolae reformation contributes to recovery from osmotic-
induced swelling (Sinha et al., 2011). The double hit to this path-
way in CLN3-null cells could explain the severe RVD phenotype.
As gatekeeper to the CNS, BBB functions are critical to neuronal
health and we thus speculate that faulty endocytosis/transcytosis,
drug efflux, and volume-regulatory pathways contribute to pro-
gressive neuronal dysfunction and loss in JNCL.
We investigated whether defective transport of microdomain-
associated proteins was accompanied by microdomain distur-
bances. Application of BODIPY-LacCer to the PM revealed a
substantial drop in excimer signal in CLN3-null cells, indicating a
relaxed association of lipids within microdomains. In addition,
excimer signal was more punctate and less patchy, suggesting
diminished domain clustering in the CLN3-deficient cells. By
FRAP, A488-CTB-GM1 diffused more rapidly into bleached re-
gions in CLN3-null relative to CLN3-restored cells. This supports
increased membrane fluidity and is consistent with the weakened
BODIPY-LacCer excimer signal. We cannot exclude potential
cytoskeletal contribution to the kinetics of fluorescence recovery.
Cytoskeletal-defined barriers may act as fences to confine molec-
ular movements within defined regions of the PM (Kusumi et al.,
2005). CLN3 has reported connections with cytoskeletal ele-
ments (Uusi-Rauva et al., 2008; Getty et al., 2011) that may act to
strengthen membrane heterogeneities in a yet-to-be defined
manner. Cumulatively, we conclude that the lipid probes signify
abnormalities in glycosphingolipid arrangements within PM mi-
crodomains of CLN3-deficient cells.
We found that CLN3 partitioned to buoyant microdomain
fractions, and immunostaining showed overlap with intracellular
GM1-positive compartments and TGN markers. These data sug-
gest that CLN3 operates within TGN microdomains to facilitate
anterograde cargo transport. In model membrane systems, phase
separation of lipids into ordered and disordered domains occurs
spontaneously, and budding is energetically favored when do-
mains reach a critical size (Baumgart et al., 2003; Hurley et al.,
2010). This is more complex in cells. Current models for carrier
formation at the Golgi or TGN incorporate protein–protein and
protein–lipid interactions and lipid modifications, to synchro-
nize membrane tubulation, bending, and fission (Bard and Mal-
hotra, 2006; Anitei and Hoflack, 2011; Ha et al., 2012).
Membrane partitioning into liquid-ordered and disordered do-
mains is becoming increasingly recognized as an important as-
pect of transport pathways from the TGN (Lippincott-Schwartz
and Phair, 2010; Surma et al., 2012). Indeed, a recent study
showed that Golgi synthesis of short-chain (in place of long-
chain) sphingomyelin boosts membrane disorder and reduces
phase separation in the Golgi, concurrent with impaired cargo
exit to the PM (Duran et al., 2012). Also, high-resolution fluores-
cence microscopy of the mammalian Golgi reveals segregation of
resident and cargo proteins into distinct membrane domains,
supporting a rapid partitioning model for sorting and transport
Figure 7. Corrective effects of LacCer. A, MBECs were untreated, or incubated for 30 min at 37°C with mock solution or LacCer added to the culture medium, and then fixed and immunostained
for caveolin-1 (cav-1), syntaxin-6 (syn6), or MDR1. LacCer was applied as a 1:1 molar complex with defatted-BSA. B, MBECs were untreated or incubated for 30 min at 37°C with mock solution or
LacCer added to the culture medium, then A488-BSA was added and uptake assessed 30 min later by fluorescence microscopy. Images are representative of three independent experiments.
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of cargo through the Golgi (Patterson et al., 2008; Lippincott-
Schwartz and Phair, 2010). Based on our current findings, our
schematic depicts CLN3 within TGN membrane domains, where
it provides a scaffolding role to facilitate microdomain coales-
cence and budding from the TGN (Fig. 8). Given that CLN3 has
been detected in various subcellular compartments, it is conceiv-
able that CLN3 is involved in membrane partitioning-based
transport from other compartments, perhaps dependent on cell
type or circumstance.
How LacCer restores trafficking of microdomain-associated
proteins is unknown. One possibility is that LacCer corrects a
sphingolipid deficiency or transport defect in CLN3-null cells.
Interestingly, prior work found that sphingolipid-deficient CHO
cells displayed defective caveolin-1 transport, caveolae formation
and caveolar endocytosis, and that exogenous application of Lac-
Cer relieved these defects (Cheng et al., 2006). Our findings are
similar. A relationship between CLN3 and sphingolipids is also
suggested by previous studies from one group which proposes
that CLN3 participates in galactosylceramide transport from the
Golgi to PM lipid rafts (Persaud-Sawin et al., 2004; Rusyn et al.,
2008). However those data are not conclusive, leaving the hypothesis
unsubstantiated. Their experiments indicated altered levels of sev-
eral sphingolipids within Triton X-100-resistant fractions from
JNCL cells. Our analysis of total cellular levels of microdomain (raft)
lipids revealed no differences between CLN3-null and CLN3-
restored MBECs. Nonetheless, in-depth investigation of a role for
CLN3 in relation to biosynthesis or intracellular transport of sphin-
golipids is warranted.
Alternatively, restorative effects of LacCer in CLN3-null
MBECs may result from delivery of supranormal levels of LacCer
to the TGN, enhancing the probability of phase partitioning and
domain-induced carrier biogenesis, and thus compensating for
the absence of a coalescence-promoting function of CLN3. In
addition, LacCer may act directly on the PM to contribute to
caveolae stabilization and endocytosis. Antibody-induced cross-
linking of PM-localized -integrin induces microdomain assem-
blage, triggering caveolae-based endocytosis (Sharma et al., 2004,
2005; Upla et al., 2004; Singh et al., 2007). Interestingly, a similar
outcome is achieved by exogenous application of LacCer alone,
and is attributed to the ability of LacCer to promote domain
clustering (Sharma et al., 2005; Singh et al., 2007). Overall our
data suggest that in the absence of CLN3 there is a reduced ability
of membrane domains to coalesce, and that LacCer relieves this
deficit. We suggest that in JNCL cells the primary defect is at the
TGN, with consequent impairment of anterograde lipid/protein
trafficking, creating an analogous defect in the PM. LacCer likely
assists at both locales in an interdependent manner.
If CLN3 helps establish or stabilize microdomains within the
TGN, one might expect disturbances in import and export path-
ways. A recent study in yeast localizes the CLN3 ortholog Btn1p
to the TGN, and demonstrates that Btn1p deficiency imparts
defects in retromer-mediated retrieval of particular cargo from
the late endosome to Golgi, in parallel with reduced Yck3-
mediated phosphorylation of a Golgi SNARE protein (Kama et
al., 2011). Cargo retrieval was restored by replacing the Yck3
palmitoylation domain with a transmembrane domain. Intrigu-
ingly, several proteins with reported ties to CLN3, such as calsenilin
(Chang et al., 2007), Yck3 (Kama et al., 2011), Rab7 (Uusi-Rauva et
al., 2012) as well as caveolin-1, are palmitoylated. Protein palmitoyl-
ation often dictates anchorage into membrane microdomains (Lev-
ental et al., 2010; Aicart-Ramos et al., 2011). Perhaps in JNCL cells,
abnormal TGN microdomains underlie poor recruitment/retention
of microdomain-associated proteins and certain palmitoylated pro-
teins are particularly affected.
In addition to sphingolipids (Persaud-Sawin et al., 2004;
Rusyn et al., 2008), alterations in phospholipids have been re-
Figure 8. Model of CLN3 in anterograde transport from the TGN. Our model predicts that CLN3 localizes to membrane microdomains in the TGN, and facilitates microdomain clustering and/or
stabilization of larger domains. This in-turn promotes the biogenesis of carrier vesicles, for TGN-to-PM transport of caveolin-1 and other microdomain-associated proteins.
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ported in JNCL tissue or cells. Bis(monoacylglycero)phosphate
was diminished in Triton X100-resistanct membranes from pa-
tient brain tissue (Hobert and Dawson, 2007). Also, the cellular
phospholipid profile was abnormal in Btn1p-deficient yeast
(Padilla-López et al., 2012). How these observations relate to
microdomain disturbance is currently unknown, but certainly
microdomain perturbations could influence microdomain-
associated enzyme activity, alter substrate access, or induce com-
pensatory changes in lipid biosynthesis.
It is increasingly appreciated that alterations in membrane
microdomain-related functions contribute to nervous system
dysfunction and neurodegeneration (Schengrund, 2010). Rele-
vant to our work, caveolin-1-deficient mice develop neurological
deficits (Trushina et al., 2006) associated with diminished synap-
tosomal protein localization to detergent-resistant buoyant frac-
tions, enhanced susceptibility to ischemic injury, and premature
neuron loss (Head et al., 2010). It will be interesting to investigate
how CLN3 loss impacts synaptic protein function and microdo-
main localization.
A diagnostic feature of NCL is the abnormal intracellular ac-
cumulation of autofluorescent material, called lipofuscin or
ceroid, in many cell types including neurons (Seehafer and
Pearce, 2006). A causative or correlative relationship with neuro-
nal dysfunction is unclear. The MBECs used in our experiments
are proliferating cells and show no evidence of lipofuscin accu-
mulation. This suggests that microdomain disturbance is a pri-
mary defect, and that autofluorescent storage buildup occurs
secondarily in postmitotic, aging cells. In studies of JNCL neuro-
nal progenitors, Fossale et al. (2004) similarly reported the occur-
rence of cellular defects in the absence of storage.
In summary, we describe loss of caveolae and related cellular
defects as pathologic features of CLN3-deficient cells. Our obser-
vations implicate impaired microdomain dynamics as a primary
determinant of the diverse cellular phenotypes noted, and a con-
tributing factor to JNCL pathology. Moreover our finding that
LacCer application has restorative effects in CLN3-null endothe-
lial cells emphasizes microdomain lipid supplement as a thera-
peutic approach worthy of further examination.
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A, Jalanko A (2008) Novel interactions of CLN3 protein link batten dis-
ease to dysregulation of fodrin-NA, K ATPase complex. Exp Cell Res
314:2895–2905. CrossRef Medline
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